Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ALCEPT; MOFIT; PHARMACOR MYCOPHENOLATE (Pharmacor Pty Ltd)
Product name
ALCEPT; MOFIT; PHARMACOR MYCOPHENOLATE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
mycophenolate mofetil
Registration type
New generic medicine
Indication
ALCEPT; MOFIT; PHARMACOR MYCOPHENOLATE (film-coated tablet) is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.
ALCEPT; MOFIT; PHARMACOR MYCOPHENOLATE is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.